Published in AIDS Weekly, March 13th, 2006
According to BioCentury, Strategy-The Inside Story, "There is really only one thing that sustainable companies must do: make sure the pipeline is full of products that will come on the market at reasonable intervals and provide reasonable levels of revenue. Given the reality of pharmaceutical failure rates, the characteristics of successful business builders are thus fairly straightforward: they spend enough on R&D and do enough partnering and acquisitions to keep the compounds flowing."
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.